Barry G. Arnason to Interferon-beta
This is a "connection" page, showing publications Barry G. Arnason has written about Interferon-beta.
Connection Strength
2.833
-
MS Forum/MS Over the Past 17 Years. Int MS J. 2011 Sep; 17(3):76-82.
Score: 0.335
-
Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b. Mult Scler. 2010 Jan; 16(1):30-8.
Score: 0.297
-
Long-term experience with interferon beta-1b (Betaferon)in multiple sclerosis. J Neurol. 2005 Sep; 252 Suppl 3:iii28-iii33.
Score: 0.221
-
Etretinate augments interferon beta-1b effects on suppressor cells in multiple sclerosis. Arch Neurol. 2001 Jan; 58(1):87-90.
Score: 0.160
-
Interferon-ß corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection. EBioMedicine. 2019 Nov; 49:269-283.
Score: 0.147
-
Treatment of multiple sclerosis with interferon beta. Biomed Pharmacother. 1999 Sep; 53(8):344-50.
Score: 0.146
-
All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis. Arch Neurol. 1998 Mar; 55(3):315-21.
Score: 0.131
-
Role of interferons in demyelinating diseases. J Neural Transm Suppl. 1997; 49:117-23.
Score: 0.121
-
Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b. Neurology. 1996 Dec; 47(6):1463-8.
Score: 0.120
-
Interferon beta in multiple sclerosis. Clin Immunol Immunopathol. 1996 Oct; 81(1):1-11.
Score: 0.119
-
Mechanisms of action of interferon-beta in multiple sclerosis. Springer Semin Immunopathol. 1996; 18(1):125-48.
Score: 0.113
-
Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b. Neurology. 1995 Dec; 45(12):2173-7.
Score: 0.112
-
Effects of inhibitors of the renin-angiotensin system on the efficacy of interferon beta-1b: a post hoc analysis of the BEYOND study. Eur Neurol. 2014; 71(3-4):173-9.
Score: 0.099
-
Interferon beta in multiple sclerosis. Neurology. 1993 Apr; 43(4):641-3.
Score: 0.093
-
Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study. J Neurol. 2013 Jul; 260(7):1838-45.
Score: 0.093
-
Variability in detection and quantification of interferon ß-1b-induced neutralizing antibodies. J Neuroinflammation. 2012 Jun 15; 9:129.
Score: 0.088
-
Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial. Mult Scler. 2012 Feb; 18(2):181-95.
Score: 0.084
-
Interferon ß-1b and glatiramer acetate effects on permanent black hole evolution. Neurology. 2011 Apr 05; 76(14):1222-8.
Score: 0.081
-
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. Lancet Neurol. 2009 Oct; 8(10):889-97.
Score: 0.073
-
Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study. Clin Ther. 2008 Jun; 30(6):1102-12.
Score: 0.067
-
Interferons in relapsing remitting multiple sclerosis. Lancet. 2003 May 24; 361(9371):1822; author reply 1823-4.
Score: 0.047
-
Immunologic therapy of multiple sclerosis. Annu Rev Med. 1999; 50:291-302.
Score: 0.035
-
Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference. Neurology. 1996 Jan; 46(1):12-8.
Score: 0.028
-
Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. Mult Scler. 2011 Dec; 17(12):1504-13.
Score: 0.021